Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: a Fortune 1000 technology firm

<Don't know there Opty, but this statement from the last PR doesn't make it sound as though there have been any basic structural changes with the original designed product.......>

I was not referring to CDX alone. You need to go to the presentation I referenced and look at the other parts of the plan which we still do not have. RG's original plan was always more than just CDX. The vision was of a more complete/comprehensive offering.

I was suggesting that the BOD may be questioning whether the rest of RG's plan is necessary. If so, how best to get there and at what cost? Either because they see money as continuing to be limited, or becuase they see a windfall and want to spend it wisely.

Opty

Share
New Message
Please login to post a reply